Volume 5, Issue 2, Summer 2026

Afficher Volume 5, Issue 2, Summer 2026
  • Relapsed Follicular Lymphoma in 2026: Evolving Treatment Strategies in the Canadian Context
  • Sequencing Therapies in Peripheral T-Cell Lymphoma
  • Front-Line Management of Mantle Cell Lymphoma in Canada: A Practical, Risk-Adapted Approach
  • Post CAR T-Cell Therapy Care: Monitoring and Toxicity Management
  • Front-line DLBCL Therapies in Canada in 2026: Biology Matters
Publié: 2026-09-24

Numéro complet

Articles